DiscoverThe ExchangeA September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25
A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

Update: 2025-08-19
Share

Description

Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now.  

Comments 
In Channel
The Exchange 9/3/25

The Exchange 9/3/25

2025-09-0346:16

The Exchange 9/2/25

The Exchange 9/2/25

2025-09-0247:10

The Exchange 8/14/25

The Exchange 8/14/25

2025-08-1446:36

The Exchange 8/13/25

The Exchange 8/13/25

2025-08-1346:46

The Exchange 8/12/25

The Exchange 8/12/25

2025-08-1245:51

The Exchange 8/11/25

The Exchange 8/11/25

2025-08-1145:55

The Exchange 8/8/25

The Exchange 8/8/25

2025-08-0844:41

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

CNBC